Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

Published Date: 24 Jan 2025

Median PFS in GEP-NETs increased from 11.5 to 29.7 with addition of lanreotide to everolimus

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combo Therapy Boosts Early CML Response but Not Long Term

2.

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

3.

In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.

4.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

5.

Classifying childhood brain cancers by immune response may improve diagnostics and treatments


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot